Biological E reduces Corbevax price to Rs 250 a dose
The decision comes within weeks of Biological E receiving the Emergency Use Authorisation (EUA) for children between five and 12 years of age. The previous private market price for the vaccine was Rs 990 a dose, including taxes and vaccine administration charges
Biological E today announced that it has reduced the price of its COVID-19 vaccine Corbevax from Rs 840 to Rs 250 a dose inclusive of GST, for private COVID-19 vaccination centres. For the end user, the price would be Rs 400 a dose, including taxes and administration charges, a company statement noted.
It also said that BE has lowered the price of its vaccine with the aim of making it more affordable and help increase the reach to protect maximum number of children against the virus. The decision comes within weeks of Biological E receiving the Emergency Use Authorisation (EUA) for children between five and 12 years of age. The previous private market price for the vaccine was Rs 990 a dose, including taxes and vaccine administration charges.
Corbevax is also offered in a single-dose vial, making it more convenient for vaccine administration. It eliminates vaccine wastage, which is a major advantage for private hospitals, added the statement.
Prior to receiving EUA for vaccination, the company conducted phase-II and -III multi-centred clinical trials in 624 children aged five to 12 years, and 12 to 18 years, the statement concluded.
- Advertisement -